Get startedLog in
    Picture of Cell Bio Human Tech Co logo

    318160 — Cell Bio Human Tech Co Cashflow Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    Consumer CyclicalsSpeculativeMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Cell Bio Human Tech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:PROSPECTUSARSAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line3,1132,890-1,8574,3798,695
    Depreciation
    Amortisation
    Non-Cash Items3,7051,5322,410-715763
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-743-5,842-5963,700-10,405
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities7,6144411,7609,2711,487
    Capital Expenditures-3,850-375-1,133-2,026-6,809
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-6864,3943,762-2,61710,609
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-4,5354,0202,630-4,6433,801
    Financing Cash Flow Items—-13,996-6,000-57.3
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities4,317-13,895-4,832-5,6237,547
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash7,676-9,434-442-95312,818